NR546/ NR 546 Midterm Exam (Latest 2026/2027 Update) | Complete Exam Questions with Verified Answers and Detailed Rationales | Psychopharmacology – Neuroanatomy, Neurotransmitters, CYP450, Antidepressants, Antipsychotics, Mood Stabilizers | A+ Graded

INSTANT PDF DOWNLOAD - This is the comprehensive Midterm Exam study guide for NR546 Advanced Psychopharmacology at Chamberlain University (Latest 2026/2027 Update), featuring 100% verified questions and answers with detailed rationales. Covers functional neuroanatomy (prefrontal cortex, amygdala, hippocampus, basal ganglia, thalamus, cerebellum, occipital lobe, central sulcus, Broca's area, Wernicke's area), neurotransmitter systems (dopamine pathways – mesolimbic, mesocortical, nigrostriatal, tuberoinfundibular; serotonin, norepinephrine, GABA, glutamate, acetylcholine), CYP450 enzyme inducers (CRAP GPS) and inhibitors (VISA CKGQ), metabolizer phenotypes, receptor pharmacology (agonist, antagonist, inverse agonist, ionotropic vs metabotropic), antidepressants (SSRIs, SNRIs, TCAs, MAOIs, bupropion, trazodone), antipsychotics (first-generation FGAs, second-generation SGAs, clozapine agranulocytosis, EPS/tardive dyskinesia, metabolic syndrome), mood stabilizers (lithium narrow therapeutic window, valproate, lamotrigine Stevens-Johnson syndrome), anxiolytics (benzodiazepines, buspirone), medication adherence, and ethical/legal considerations. INSTANT DIGITAL DOWNLOAD (PDF) immediately upon purchase. Fully text-searchable, printable, and accessible anytime. Trusted by Chamberlain PMHNP students for Midterm Exam success. 100% satisfaction guarantee. NR546 Midterm Exam Chamberlain NR 546 Psychopharmacology Midterm Functional Neuroanatomy Prefrontal Cortex Executive Function Amygdala Emotion Fear Hippocampus Memory Limbic System Emotion Regulation Basal Ganglia Motor Control Movement Disorders Broca's Area Speech Production Wernicke's Area Speech Comprehension Central Sulcus Frontal Parietal Lobe Separation Occipital Lobe Vision Thalamus Sensory Relay Dopamine Pathways Mesolimbic Reward Positive Symptoms Mesocortical Negative Symptoms Nigrostriatal Movement EPS Tuberoinfundibular Prolactin Levels Serotonin 5HT Mood Regulation Appetite Sleep Norepinephrine Locus Coeruleus Arousal Attention GABA Primary Inhibitory Neurotransmitter Anxiety Reduction Glutamate Primary Excitatory Neurotransmitter Neurotoxicity CYP450 Inducers CRAP GPS Carbamazepine Rifampin Alcohol Phenytoin Griseofulvin Phenobarbital St John's Wort CYP450 Inhibitors VISA CKGQ Valproate Isoniazid Sulfonamides Amiodarone Ketoconazole Grapefruit Juice Quinidine Poor Metabolizer Lower Enzyme Activity Higher Drug Levels Side Effects Ultrarapid Metabolizer Higher Enzyme Activity Subtherapeutic Levels SSRIs First Line Depression Fluoxetine Sertraline Escitalopram Paroxetine Fluvoxamine Sexual Dysfunction SNRIs Venlafaxine Duloxetine Desvenlafaxine Levomilnacipran Bupropion Wellbutrin NDRI Insomnia Seizure Risk Smoking Cessation MAOIs Phenelzine Tranylcypromine Hypertensive Crisis Tyramine Diet First Generation Antipsychotics Haloperidol D2 Antagonist EPS Tardive Dyskinesia Second Generation Antipsychotics Clozapine Risperidone Olanzapine Quetiapine Aripiprazole Clozapine Black Box Warning Agranulocytosis ANC Monitoring Life Threatening Olanzapine Quetiapine Metabolic Syndrome Weight Gain Diabetes Dyslipidemia EPS Extrapyramidal Symptoms Dystonia Akathisia Parkinsonism Tardive Dyskinesia AIMS Scale Abnormal Involuntary Movement Scale Tardive Dyskinesia Monitoring Lithium Bipolar Disorder Narrow Therapeutic Window 0.6-1.2 mEq/L NSAIDs ACE Inhibitors Toxicity Valproate Depakote Bipolar Mania Lamotrigine Black Box Warning Stevens Johnson Syndrome Slow Titration Benzodiazepines GABA A Agonist Anxiety Dependence Risk Withdrawal Seizure Buspirone Buspar 5HT1A Partial Agonist No Sedation No Dependence No Abuse Liability Chemical Restraints Court Order Standing Orders Allergy Status Chamberlain NR546 Test Bank PMHNP Psychopharmacology Midterm A+ Graded PMHNP Study Guide